PD-1 inhibitor (anti-PD-1 monoclonal antibody)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-1 inhibitor (anti-PD-1 monoclonal antibody), covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Akkermansia Probiotics Plus Anti-PD-1 Monoclonal Antibody in MSS/pMMR Advanced Colorectal Cancer [NA]